ID
25735
Beschrijving
Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876 Study ID: 100789 Clinical Study ID: NKV100789 Study Title: A two-part, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of single intravenous doses of GW679769 when administered alone and in combination with intravenous or oral doses of dexamethasone in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced
Trefwoorden
Versies (1)
- 16-09-17 16-09-17 -
Houder van rechten
glaxoSmithKline
Geüploaded op
16 september 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Beschrijving
Study medication oral
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0304229
- UMLS CUI-3
- C1527415
Beschrijving
Dosing day
Datatype
partialDate
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439228
Beschrijving
Session hour
Datatype
partialDatetime
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439227
Beschrijving
Session minute
Datatype
partialDatetime
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439232
Beschrijving
Start dose date
Datatype
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0178602
Beschrijving
Start dose time
Datatype
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0178602
Beschrijving
Dose amount
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1264637
Beschrijving
Dose unit
Datatype
text
Alias
- UMLS CUI [1]
- C0869039
Beschrijving
Dose form
Datatype
text
Alias
- UMLS CUI [1]
- C0013058
Beschrijving
Dose route
Datatype
text
Alias
- UMLS CUI [1,1]
- C0013153
- UMLS CUI [1,2]
- C0679006
Beschrijving
Study Medication IV
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0304229
- UMLS CUI-3
- C1522726
Beschrijving
Dosing day
Datatype
partialDate
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439228
Beschrijving
Session hour
Datatype
partialDatetime
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439227
Beschrijving
Session minute
Datatype
partialDatetime
Alias
- UMLS CUI [1,1]
- C1883016
- UMLS CUI [1,2]
- C0439232
Beschrijving
Start dose date
Datatype
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0178602
Beschrijving
Start dose time
Datatype
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C0178602
Beschrijving
End Dose Date
Datatype
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C0178602
Beschrijving
End Dose Time
Datatype
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C0178602
Beschrijving
Start Dose Volume
Datatype
text
Alias
- UMLS CUI [1,1]
- C0449468
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0439659
Beschrijving
End Dose Volume
Datatype
text
Alias
- UMLS CUI [1,1]
- C0449468
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0444930
Beschrijving
Dose amount
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1264637
Beschrijving
Dose unit
Datatype
text
Alias
- UMLS CUI [1]
- C0869039
Beschrijving
Dose form
Datatype
text
Alias
- UMLS CUI [1]
- C0013058
Beschrijving
Dose route
Datatype
text
Alias
- UMLS CUI [1,1]
- C0013153
- UMLS CUI [1,2]
- C0679006
Similar models
Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
C0679006 (UMLS CUI-2)
C0679006 (UMLS CUI [1,2])
C0304229 (UMLS CUI-2)
C1527415 (UMLS CUI-3)
C0439228 (UMLS CUI [1,2])
C0439227 (UMLS CUI [1,2])
C0439232 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C1264637 (UMLS CUI [1,2])
C0679006 (UMLS CUI [1,2])
C0304229 (UMLS CUI-2)
C1522726 (UMLS CUI-3)
C0439228 (UMLS CUI [1,2])
C0439227 (UMLS CUI [1,2])
C0439232 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0439659 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0444930 (UMLS CUI [1,3])
C1264637 (UMLS CUI [1,2])
C0679006 (UMLS CUI [1,2])